Diagnostik Purchases HIV/AIDS Specialty Pharmacy Company

Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Diagnostik Purchases HIV/AIDS Specialty Pharmacy Company

PR Newswire (10/27/93)

Albuquerque, N.M.--Diagnostik, Inc. has announced the $9 million acquisition of Chronitech Health Services, Inc., which provides specialty pharmacy, homecare medication, and infusion services to the HIV/AIDS market. "This acquisition enables Diagnostik to respond quickly to the growing need for quality, reliable specialized pharmacy services," said Nunzio DeSantis, chairman and CEO of Diagnostik. "The prescription market for HIV and AIDS is largely unmanaged. We'll coordinate pharmacy care in accordance with our managed care philosophy, emphasizing choice, clinical pharmacy expertise, and comprehensive information management." The RxChoice program, a point-of-service medical drug program that allows patients to fill prescriptions at a national preferred retail pharmacy network, will also benefit AIDS patients. "Prescription drug bills for AIDS patients are staggering, often exceeding $10,000 per person annually," says DeSantis. "Our RxChoice prescription program offers affordable, accessible pharmacy care, with a premium on service and quality. We're extremely pleased to be able to extend our help to those people suffering from HIV and AIDS. Diagnostik also offers a state- of-the-art mail service for patients to fill maintenance prescriptions, a key benefit for long-term AIDS-related drug therapies.

931029
AD931969

Copyright © 1993 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.